Improves Type News Today : Breaking News, Live Updates & Top Stories | Vimarsana
Stay updated with breaking news from Improves type. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Top News In Improves Type Today - Breaking & Trending Today
Inventiva SA (NASDAQ: IVA) announced the topline results of Phase 2 clinical study evaluating lanifibranor in patients with NAFLD and type 2 diabetes mellitus. The study achieved the primary efficacy endpoint with a 44% reduction of Intra Hepatic Triglycerides (fat in the bloodstream) compared to 12% in the placebo arm. This result is consistent with the Phase 2b NATIVE trial findings, in which lanifibranor demonstrated a statistically significant effect on steatosis reduction as measured by CAP ....